Vusion Heads Into Earnings With Borrow Fully Seized
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
VU enters its November 5 earnings release with the lending market for its shares at a standstill, cost to borrow running above 22%, and the stock up 10% on the week.
The lending picture is as tight as it gets. Availability has collapsed to just 0.18%, meaning virtually every share in the pool has already been lent out. A week ago availability was above 10%, so the squeeze on supply has been rapid and severe. Cost to borrow has held in a range of 21% to 25% for most of October, with only a brief spike to 32% in mid-October breaking that band. At 22.5%, borrowing this stock costs short sellers roughly a quarter of its value per year. The ORTEX short score has been locked above 93 for the past two weeks, a level that places VU in the top percentile of the coverage universe for short-side pressure. Factor scores confirm the same picture: the utilisation rank and days-to-cover rank are both near the floor of the distribution, reflecting an extremely constrained lending pool rather than a stock where shorts have room to manoeuvre.
The Street, however, is firmly in the bull camp. Six analysts carry buy ratings with a consensus price target of around EUR 208, a meaningful premium to Friday's close of EUR 136.90. No analyst changes have been filed recently enough to move the story. Valuation multiples are not demanding by historical standards: the trailing price-to-earnings ratio has drifted up about 0.65 points over the past month to around 12.5x, while EV/EBITDA is close to 5x. The earnings yield factor scores at 72nd percentile and EV/EBIT at 78th, suggesting the stock is not obviously expensive relative to the broader universe. EPS momentum, however, is a clear weak spot: the 30-day and 90-day readings rank in the 14th and 26th percentiles respectively, and the 12-month forward earnings growth factor sits at just the 10th percentile. Bulls are buying the structural retail automation story; the earnings momentum data suggests delivery has been inconsistent.
Ownership is concentrated enough to be worth noting. Beijing Electronics Holding holds 24% of shares, co-founder S.E. Sim holds a further 10%, and Bpifrance Participations carries nearly 8%. These three alone account for over 42% of shares. E Ink Holdings, a key technology partner, holds close to 6%. That concentration means the free float is thin, which helps explain why availability can collapse so quickly when demand for borrows rises. The most recent open-market buying from named insiders came in late April, when board member Peter Brabeck-Letmathe purchased 125,000 shares across several days at prices in the EUR 132 to EUR 137 range, putting him at cost very close to where the stock trades today.
The last earnings event produced a notable reaction: the stock moved just over 11% higher on the day and held most of that gain over the following week. The print before that generated a more modest 3% single-day move. With availability now at effectively zero and a 10% rally already in the price heading into Thursday's release, the setup entering this print is more charged than the previous two.
What to watch on November 5 is whether the revenue trajectory on retail digitisation contracts in North America and Europe can justify the analyst consensus that sits roughly 50% above the current share price, and whether the lending market loosens or tightens further in the 48 hours around the announcement.
Stocks in this article
See the live data behind this article on ORTEX.
Open VU on ORTEX →How this article was generated
- Generated
- 3 Nov 2026, 17:32
- Data as of
- 3 Nov 2026, 17:32
- Prompt version
- v1.0
- Data sources
- Cost to borrowUtilizationEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notes
- Validation notes
- soft: missing section mentions: short interest (informational only)
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.